DCM
SRPT icon

Driehaus Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Driehaus Capital Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,154
Closed -$367K – 517
2020
Q4 		$367K Sell
2,154
-4,580
-68% -$679K 0.01% 385
2020
Q3 		$946K Sell
6,734
-6,116
-48% -$929K 0.02% 292
2020
Q2 		$2.06M Buy
12,850
+10,127
+372% +$1.38M 0.05% 258
2020
Q1 		$266K Sell
2,723
-3,400
-56% -$389K 0.01% 356
2019
Q4 		$790K Buy
+6,123
New +$618K 0.02% 321
2019
Q3 		– Sell
-52,360
Closed -$7.96M – 564
2019
Q2 		$7.96M Buy
52,360
+4,220
+9% +$513K 0.25% 110
2019
Q1 		$5.74M Buy
48,140
+12,892
+37% +$1.66M 0.22% 129
2018
Q4 		$3.85M Sell
35,248
-8,922
-20% -$1.12M 0.16% 158
2018
Q3 		$7.13M Sell
44,170
-21,576
-33% -$2.95M 0.22% 143
2018
Q2 		$8.69M Buy
65,746
+11,217
+21% +$1.06M 0.29% 107
2018
Q1 		$4.04M Sell
54,529
-25,937
-32% -$1.73M 0.14% 185
2017
Q4 		$4.48M Buy
80,466
+7,510
+10% +$398K 0.17% 164
2017
Q3 		$3.31M Buy
+72,956
New +$2.92M 0.13% 198
2016
Q4 		– Sell
-37,375
Closed -$2.29M – 640
2016
Q3 		$2.29M Buy
+37,375
New +$1.13M 0.08% 249
2013
Q4 		– Sell
-44,170
Closed -$2.09M – 522
2013
Q3 		$2.09M Sell
44,170
-6,632
-13% -$255K 0.08% 274
2013
Q2 		$1.93M Buy
+50,802
New +$1.82M 0.08% 270

Other funds holding SRPT

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Driehaus Capital Management's SRPT Position: Q1 2021 in Review

Driehaus Capital Management sold out of Sarepta Therapeutics (SRPT) in Q1 2021, closing a stake of 2,154 shares — an estimated $367K sold.

Driehaus Capital Management first reported a position in SRPT in Q2 2013 and held it in 16 quarters. The position peaked at $8.69M in Q2 2018. 366 funds tracked by Wall St. Rank hold SRPT as of Q1 2021.

  • Driehaus Capital Management reported no remaining Sarepta Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Driehaus Capital Management sold 2,154 Sarepta Therapeutics shares in Q1 2021, an estimated $367K.
  • Driehaus Capital Management first reported a position in Sarepta Therapeutics in Q2 2013 and held it in 16 quarters.
  • Driehaus Capital Management's Sarepta Therapeutics position peaked at $8.69M in Q2 2018.
  • 366 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2021.

Based on Driehaus Capital Management's 13F filing for Q1 2021, filed 17 May 2021.